Tech Company Financing Transactions
Zafrens Funding Round
Zafrens secured a $31 million funding round on 2/4/2025. Investors included Global Brain, imec.xpand and KOFA Healthcare Investments.
Transaction Overview
Company Name
Announced On
2/4/2025
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Undisclosed
Proceeds Purpose
The new funding will enable Zafrens to expand its capacity and engage in additional partnerships with pharmaceutical companies worldwide.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5890 Pacific Center Blvd. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Z-Screen replaces the conventional 96-well plate experimental format with a 50,000 - 200,000 well plate format containing a built-in mRNA sequencer. This allows every cell that is imaged in an assay to be sequenced, as well, revealing rich causal relationships between perturbations, molecular responses, cell function and cell interactions. Unlike traditional high-throughput screening, Z-Screen does not rely on robotics for its scale. Nanofabrication innovations allow millions of experiments to be performed per day on a benchtop instrument.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Swamy Vijayan
Browse more venture capital transactions:
Prev: 2/4/2025: PlantBaby venture capital transaction
Next: 2/4/2025: Sotira venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs